Endothelial function in patients with newly diagnosed type 2 diabetes receiving early intensive insulin therapy

Jing Tian, Jingfeng Wang, Yan Li, Daniel Villarreal, Robert Carhart, Yanbin Dong, Yanling Wen, Kan Liu

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Background Multifactorial intervention is unable to improve endothelial dysfunction/cardiovascular outcome in type 2 diabetes. Intensive insulin therapy improves pancreatic β-cell dysfunction in patients with early stage diabetes. We investigated the effect of intensive insulin therapy on endothelial dysfunction in these patients.MethodsOne hundred and sixteen patients with newly diagnosed type 2 diabetes and 59 healthy subjects received flow-mediated dilatation (FMD) and von Willebrand factor (vWF) measurement. Diabetic patients were further treated with either multifactorial intervention (group A), or intensive insulin therapy (group B) for 2 weeks. Both FMD and vWF measurement were repeated at the same time. FMD was reassessed 90 days after intervention.ResultsCompared with healthy subjects, FMD in diabetic patients was significantly lower (group A: 15.99 ± 7.81 % vs. 25.17 ± 7.12 %, P < 0.01; group B: 16.85 ± 7.30 % vs. 25.17 ± 7.12%, P < 0.01), plasma vWF was significantly higher (group A: 224.34 ± 7.36 U/l vs. 109.69 ± 6.30 U/l, P < 0.01; group B: 219.18 ± 6.92 U/l vs. 109.69 ± 6.30 U/l, P < 0.01). After treatment, there was no significant change of FMD in either group. The vWF did not change after multifactorial intervention (220.96 ± 6.85 U/l vs. 224.34 ± 7.36 U/l, P = 0.49), but significantly decreased after intensive insulin therapy (155.08 ± 11.82 U/l vs. 219.18 ± 6.92 U/l, P = 0.0013).ConclusionsIntensive insulin therapy significantly improves endothelial injury/dysfunction as measured by vWF in early stage type 2 diabetes. Further study is needed to determine whether plasma vWF can help early identification, stratification and management of diabetic endothelial dysfunction.

Original languageEnglish (US)
Pages (from-to)1242-1248
Number of pages7
JournalAmerican journal of hypertension
Volume25
Issue number12
DOIs
StatePublished - Dec 1 2012

Fingerprint

von Willebrand Factor
Type 2 Diabetes Mellitus
Dilatation
Insulin
Healthy Volunteers
Therapeutics
Group Psychotherapy
Wounds and Injuries

Keywords

  • blood pressure
  • brachial artery flow-mediated dilation
  • early intensive insulin therapy
  • hypertension
  • type 2 diabetes
  • vascular endothelial dysfunction
  • von Willebrand factor

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Endothelial function in patients with newly diagnosed type 2 diabetes receiving early intensive insulin therapy. / Tian, Jing; Wang, Jingfeng; Li, Yan; Villarreal, Daniel; Carhart, Robert; Dong, Yanbin; Wen, Yanling; Liu, Kan.

In: American journal of hypertension, Vol. 25, No. 12, 01.12.2012, p. 1242-1248.

Research output: Contribution to journalArticle

Tian, Jing ; Wang, Jingfeng ; Li, Yan ; Villarreal, Daniel ; Carhart, Robert ; Dong, Yanbin ; Wen, Yanling ; Liu, Kan. / Endothelial function in patients with newly diagnosed type 2 diabetes receiving early intensive insulin therapy. In: American journal of hypertension. 2012 ; Vol. 25, No. 12. pp. 1242-1248.
@article{914464dd01254ae394cad1d1ef2e38d8,
title = "Endothelial function in patients with newly diagnosed type 2 diabetes receiving early intensive insulin therapy",
abstract = "Background Multifactorial intervention is unable to improve endothelial dysfunction/cardiovascular outcome in type 2 diabetes. Intensive insulin therapy improves pancreatic β-cell dysfunction in patients with early stage diabetes. We investigated the effect of intensive insulin therapy on endothelial dysfunction in these patients.MethodsOne hundred and sixteen patients with newly diagnosed type 2 diabetes and 59 healthy subjects received flow-mediated dilatation (FMD) and von Willebrand factor (vWF) measurement. Diabetic patients were further treated with either multifactorial intervention (group A), or intensive insulin therapy (group B) for 2 weeks. Both FMD and vWF measurement were repeated at the same time. FMD was reassessed 90 days after intervention.ResultsCompared with healthy subjects, FMD in diabetic patients was significantly lower (group A: 15.99 ± 7.81 {\%} vs. 25.17 ± 7.12 {\%}, P < 0.01; group B: 16.85 ± 7.30 {\%} vs. 25.17 ± 7.12{\%}, P < 0.01), plasma vWF was significantly higher (group A: 224.34 ± 7.36 U/l vs. 109.69 ± 6.30 U/l, P < 0.01; group B: 219.18 ± 6.92 U/l vs. 109.69 ± 6.30 U/l, P < 0.01). After treatment, there was no significant change of FMD in either group. The vWF did not change after multifactorial intervention (220.96 ± 6.85 U/l vs. 224.34 ± 7.36 U/l, P = 0.49), but significantly decreased after intensive insulin therapy (155.08 ± 11.82 U/l vs. 219.18 ± 6.92 U/l, P = 0.0013).ConclusionsIntensive insulin therapy significantly improves endothelial injury/dysfunction as measured by vWF in early stage type 2 diabetes. Further study is needed to determine whether plasma vWF can help early identification, stratification and management of diabetic endothelial dysfunction.",
keywords = "blood pressure, brachial artery flow-mediated dilation, early intensive insulin therapy, hypertension, type 2 diabetes, vascular endothelial dysfunction, von Willebrand factor",
author = "Jing Tian and Jingfeng Wang and Yan Li and Daniel Villarreal and Robert Carhart and Yanbin Dong and Yanling Wen and Kan Liu",
year = "2012",
month = "12",
day = "1",
doi = "10.1038/ajh.2012.122",
language = "English (US)",
volume = "25",
pages = "1242--1248",
journal = "American Journal of Hypertension",
issn = "0895-7061",
publisher = "Oxford University Press",
number = "12",

}

TY - JOUR

T1 - Endothelial function in patients with newly diagnosed type 2 diabetes receiving early intensive insulin therapy

AU - Tian, Jing

AU - Wang, Jingfeng

AU - Li, Yan

AU - Villarreal, Daniel

AU - Carhart, Robert

AU - Dong, Yanbin

AU - Wen, Yanling

AU - Liu, Kan

PY - 2012/12/1

Y1 - 2012/12/1

N2 - Background Multifactorial intervention is unable to improve endothelial dysfunction/cardiovascular outcome in type 2 diabetes. Intensive insulin therapy improves pancreatic β-cell dysfunction in patients with early stage diabetes. We investigated the effect of intensive insulin therapy on endothelial dysfunction in these patients.MethodsOne hundred and sixteen patients with newly diagnosed type 2 diabetes and 59 healthy subjects received flow-mediated dilatation (FMD) and von Willebrand factor (vWF) measurement. Diabetic patients were further treated with either multifactorial intervention (group A), or intensive insulin therapy (group B) for 2 weeks. Both FMD and vWF measurement were repeated at the same time. FMD was reassessed 90 days after intervention.ResultsCompared with healthy subjects, FMD in diabetic patients was significantly lower (group A: 15.99 ± 7.81 % vs. 25.17 ± 7.12 %, P < 0.01; group B: 16.85 ± 7.30 % vs. 25.17 ± 7.12%, P < 0.01), plasma vWF was significantly higher (group A: 224.34 ± 7.36 U/l vs. 109.69 ± 6.30 U/l, P < 0.01; group B: 219.18 ± 6.92 U/l vs. 109.69 ± 6.30 U/l, P < 0.01). After treatment, there was no significant change of FMD in either group. The vWF did not change after multifactorial intervention (220.96 ± 6.85 U/l vs. 224.34 ± 7.36 U/l, P = 0.49), but significantly decreased after intensive insulin therapy (155.08 ± 11.82 U/l vs. 219.18 ± 6.92 U/l, P = 0.0013).ConclusionsIntensive insulin therapy significantly improves endothelial injury/dysfunction as measured by vWF in early stage type 2 diabetes. Further study is needed to determine whether plasma vWF can help early identification, stratification and management of diabetic endothelial dysfunction.

AB - Background Multifactorial intervention is unable to improve endothelial dysfunction/cardiovascular outcome in type 2 diabetes. Intensive insulin therapy improves pancreatic β-cell dysfunction in patients with early stage diabetes. We investigated the effect of intensive insulin therapy on endothelial dysfunction in these patients.MethodsOne hundred and sixteen patients with newly diagnosed type 2 diabetes and 59 healthy subjects received flow-mediated dilatation (FMD) and von Willebrand factor (vWF) measurement. Diabetic patients were further treated with either multifactorial intervention (group A), or intensive insulin therapy (group B) for 2 weeks. Both FMD and vWF measurement were repeated at the same time. FMD was reassessed 90 days after intervention.ResultsCompared with healthy subjects, FMD in diabetic patients was significantly lower (group A: 15.99 ± 7.81 % vs. 25.17 ± 7.12 %, P < 0.01; group B: 16.85 ± 7.30 % vs. 25.17 ± 7.12%, P < 0.01), plasma vWF was significantly higher (group A: 224.34 ± 7.36 U/l vs. 109.69 ± 6.30 U/l, P < 0.01; group B: 219.18 ± 6.92 U/l vs. 109.69 ± 6.30 U/l, P < 0.01). After treatment, there was no significant change of FMD in either group. The vWF did not change after multifactorial intervention (220.96 ± 6.85 U/l vs. 224.34 ± 7.36 U/l, P = 0.49), but significantly decreased after intensive insulin therapy (155.08 ± 11.82 U/l vs. 219.18 ± 6.92 U/l, P = 0.0013).ConclusionsIntensive insulin therapy significantly improves endothelial injury/dysfunction as measured by vWF in early stage type 2 diabetes. Further study is needed to determine whether plasma vWF can help early identification, stratification and management of diabetic endothelial dysfunction.

KW - blood pressure

KW - brachial artery flow-mediated dilation

KW - early intensive insulin therapy

KW - hypertension

KW - type 2 diabetes

KW - vascular endothelial dysfunction

KW - von Willebrand factor

UR - http://www.scopus.com/inward/record.url?scp=84869205085&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84869205085&partnerID=8YFLogxK

U2 - 10.1038/ajh.2012.122

DO - 10.1038/ajh.2012.122

M3 - Article

VL - 25

SP - 1242

EP - 1248

JO - American Journal of Hypertension

JF - American Journal of Hypertension

SN - 0895-7061

IS - 12

ER -